Impact Factor
4.23
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.04
4,414 total citations
h5-index
71
h5 depth signal
Cited share
77.3%
720 of 932
Total citations
4,414
Citation footprint
Metric signal
5.57
External metric anchor
Self-citation
1.7%
77 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,488
China
1,309
Germany
901
United Kingdom
631
France
630
Citing Fields of Research
Oncology
2,172
Breast Cancer
926
Liver & Colon Cancer
784
Immunology
593
Cancer & Development
489
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
30,378
Articles tracked across the journal lifetime
Indexed publication set
932
720 cited publications
Last 12 months
580
48.3 publications/month
Open access share
51.9%
301 OA publications in the last year
Leading citing country
United States
1,488 citing publications
Leading citing field
Oncology
2,172 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 1966-
v1n1, Jan. 1966-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Liver & Colon Cancer
Lung Cancer
Immunology
Issuing & Sponsoring Bodies
Contributor
Fundação Calouste Gulbenkian
Contributor
International Union against Cancer
Contributor
National Institutes of Health (U.S.)
Broad Categories
Neoplasms
Oncology
Breast Cancer
Liver & Colon Cancer
Immunology
Lung Cancer
Digestive Disorders
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/ijc.70795
Open DOI
Outcomes Following Pancreatoduodenectomy With Arterial Resection: A NSQIP Analysis Comparing Trends in Patient Selection and Outcomes to Venous or no Vascular Resection Over 5 Years
Evaluation of arterial resection (AR) during pancreatoduodenectomy (PD) remains limited. This study compares PD with AR to PD with venous resection (VR) and no vascular resection (NVR). Patient demographics, outcomes, and changes over 5 ...
02
DOI 10.1002/ijc.70780
Open DOI
Epstein–Barr Virus Association and Prognosis in Taiwanese Hodgkin Lymphoma: A Nationwide Multicenter Study With Comparison to United States Whites
Hodgkin lymphoma (HL) is associated with Epstein–Barr virus (EBV) infection in a subset of cases. We previously showed that the incidence of HL in Taiwan increased ~2.5‐fold between 2001 and 2020, particularly among young women with the ...
03
DOI 10.1002/ijc.70765
Open DOI
BRCAness ‐Driven Prognostic Model and Regimen‐Specific Therapeutic Implications in Triple‐Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
BRCAness, a phenotype associated with homologous recombination deficiency, has not been fully characterized in triple‐negative breast cancer (TNBC) with residual disease after neoadjuvant chemotherapy (NAC), especially regarding prognosi...
04
DOI 10.1002/ijc.70753
Open DOI
Controlled Trial of Cervical Cancer Screening Frequency Among Human Papillomavirus Vaccinated Women II : Cervical Pre‐Cancer End‐Points by Specific Non‐Vaccine HPV Types
We conducted a controlled trial among 5626 early adolescent women vaccinated in 2007–2009 against human papillomavirus (HPV) types 16/18 to evaluate the impact of high‐intensity versus low‐intensity cervical screening, respectively at ag...
05
DOI 10.1002/ijc.70797
Open DOI
Cancer in the Oldest‐Old in Super‐Aging Japan: Trends and Characteristics From National Registry Data
Globally, Japan has the largest proportion of individuals aged ≥ 85 years. However, epidemiological studies on cancer in this age group are limited. This study aimed to investigate cancer trends and characteristics among the oldest‐old a...
06
DOI 10.1002/ijc.70777
Open DOI
Correction to “ RIST : A Potent New Combination Therapy for Glioblastoma”
07
DOI 10.1002/ijc.70790
Open DOI
MLH1 p. His112Arg Variant Is Associated With Increased Cancer Susceptibility
Lynch syndrome, a prevalent hereditary cancer predisposition, is frequently caused by pathogenic variants in the MutL homolog 1 (MLH1) mismatch repair gene. However, a significant proportion of MLH1 missense variants remain classified as...
08
DOI 10.1002/ijc.70789
Open DOI
Real‐World Experience With Multimodal Treatment of Resectable Stage II – III Non‐Small Cell Lung Cancer: A Single Institutional Analysis
Neoadjuvant therapy has recently become an integral component of multimodal treatment for resectable lung cancer. However, real‐world data on perioperative morbidity and treatment adherence remain limited. This study aimed to assess the ...
09
DOI 10.1002/ijc.70781
Open DOI
Familial Cancers Associated With Cancers of the Breast, Prostate, Colorectum, and Lung in Sweden
Available epidemiological evidence shows that many cancers share familial risks, and this is increasingly confirmed by data on shared pathogenic germline gene variants between cancers. We decided to harness the world's largest resource o...
10
DOI 10.1002/ijc.70779
Open DOI
Oral and Fecal Microbial Dysbiosis as Non‐Invasive Diagnostic Biomarkers for Gastrointestinal Cancers: A Systematic Review and Meta‐Analysis of Diagnostic Accuracy
Gastrointestinal (GI) cancers, including esophageal (EC), gastric (GC), and colorectal cancer (CRC), impose a substantial global burden, with early detection remaining crucial for improving patient outcomes. The oral and gut microbiota a...
Bibliographical & Catalog Notes
Vol. numbering of additional annual vols. follows after that of main title each year, e.g., for 2000, v. 85-88 = International journal of cancer; v. 89 = International journal of cancer. Predictive oncology; v. 90 = International journal of cancer. Radiation oncology investigations.
Also issued online.
Articles in English or French with summary in the language not used.
Issued by the International Union Against Cancer, with the assistance of the National Institutes of Health (Grant CA 05096-05) and the Calouste Gulbenkian Foundation.
(1989)19890816 Notice published Printed on acid-free paper